SBI Securities
BRTX icon

SBI Securities’s BioRestorative Therapies BRTX Stock Holding History

SBI Securities’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$263 Buy
35
+25
+250% +$146 ﹤0.01% 3240
2026
Q1 		$54 Buy
10
+4
+67% +$51 ﹤0.01% 3559
2025
Q4 		$140 Buy
6
+1
+20% +$27 ﹤0.01% 3313
2025
Q3 		$152 Buy
5
+1
+25% +$31 ﹤0.01% 3402
2025
Q2 		$148 Hold
4
– – ﹤0.01% 3409
2025
Q1 		$132 Buy
4
+1
+33% +$38 ﹤0.01% 3360
2024
Q4 		$86 Buy
+3
New +$93 ﹤0.01% 3498

Other funds holding BRTX

Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KFGK
Keystone Financial Group (Kentucky) Lexington, Kentucky $1.69B AUM 40.17% 1-Year Est. Return

SBI Securities's BRTX Position: Q2 2026 in Review

SBI Securities increased its BioRestorative Therapies (BRTX) stake by 250% in Q2 2026, buying an estimated $146 and bringing the position to 35 shares worth $263. The position accounts for ﹤0.01% of the portfolio, ranked #3240.

SBI Securities first reported a position in BRTX in Q4 2024 and has held it in 7 quarters since. 18 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

  • SBI Securities held 35 shares of BioRestorative Therapies worth $263 as of Q2 2026.
  • SBI Securities bought 25 BioRestorative Therapies shares in Q2 2026, an estimated $146.
  • BioRestorative Therapies made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3240 holding.
  • SBI Securities first reported a position in BioRestorative Therapies in Q4 2024 and has held it in 7 quarters since.
  • 18 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.